Integral Health Asset Management »

Illumina shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Illumina (ILMN) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Illumina

Tip: Access up to 7 years of quarterly data

All positions including Illumina held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Illumina by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.3M 40k 133.63
2022-09-30 $5.7M 30k 190.80

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Illumina

Capital World Investors
BlackRock
Vanguard Group
State Street Corporation
Sessa Capital IM
Loomis, Sayles and
WCM Investment Management
Corvex Management
PointState Capital
AQR Capital Management
Geode Capital Management
Henderson Group
PRIMECAP Management Company
Guardcap Asset Management
Baillie Gifford & Co

View all funds holding Illumina